Reporter models for the Evaluation of Diseases involving OXidative stress
"Perturbations in cellular redox status are implicated in many human diseases, yet there is an extreme lack of knowledge about the effects of oxidative stress in vivo, mainly due to difficulties in measuring reactive oxygen specie...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
RADMED
Radical Medicine Redefining Oxidative Stress
2M€
Cerrado
MFROSPEP
Designing metallopeptides for the removal of superoxide radi...
100K€
Cerrado
ROS IN CELL FATE
Influence of oxidants on cell fate determination by use of a...
159K€
Cerrado
CARDIOREDOX
Redox sensing and signalling in cardiovascular health and di...
2M€
Cerrado
BFU2016-80006-P
FUNCION DE LAS PEROXIRREDOXINAS EN LA HOMEOSTASIS CELULAR CO...
157K€
Cerrado
BES-2016-076518
FUNCION DE LAS ESPECIES DE OXIGENO Y NITROGENO REACTIVOS (RO...
93K€
Cerrado
Información proyecto REDOX
Líder del proyecto
UNIVERSITY OF DUNDEE
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
2M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
"Perturbations in cellular redox status are implicated in many human diseases, yet there is an extreme lack of knowledge about the effects of oxidative stress in vivo, mainly due to difficulties in measuring reactive oxygen species (ROS) in vivo and the absence of experimental models. REDOX will use novel transgenic technologies to develop mouse models that report on ROS in vivo, allowing spatio-temporal monitoring of different types of oxidative stress, ultimately simultaneously in a complex reporter line, and clarifying its role in the aetiology of disease and pathways of drug & chemical toxicity. These models will reveal oxidative stress as a primary cause, or a consequence, of the disease process. Reporters will be driven by endogenous genes regulated by different forms of oxidative stress and, uniquely, we will exploit the sophisticated redox sensing systems in bacteria to discern different types of ROS. In a sophisticated system we will express 3 reporters from the same stress regulated promotor, generating a polycistronic mRNA by use of the FMDV 2A sequence, which cleaves the nascent polypeptide to yield the endogenous gene product and individual reporters. LacZ will be used as an in situ reporter, luciferase for imaging, and a secreted protein, eg hCG, as a non-invasive biomarker in blood or urine. The in vivo role of oxidative stress in disease aetiology, and the potential of novel anti-oxidants to prevent such diseases, will be evaluated in these models. A further novel aspect will be to generate ES cells from the reporter lines, and create genetically-driven disease models which reflect inherited human diseases. REDOX combines ambitious experimental systems with sophisticated novel technologies to create models to define the role of oxidative stress in human disease, offering a new approach in defining and testing of disease prevention and therapeutic interventions while reducing the number of animals required."